Sort
50,496 grants matching “lung cancer”
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$507,875Stephen S Hecht · University Of Minnesota · R01 · FY2015 · CA
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$507,853Stephen S Hecht · University Of Minnesota · R01 · FY2018 · CA
Evaluating Lung Cancer Screening Patterns and Outcomes in Diverse Populations and Settings
$507,725Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK
$507,677Philip Lazarus · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · DE
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling
$507,671Jacob Gardinier Scott · Cleveland Clinic Lerner Com-Cwru · U01 · FY2024 · CA
The Effectiveness, Safety, and Costs of Guideline-Concordant Lung Nodule Care
$507,649Farhood Farjah · University Of Washington · R01 · FY2019 · CA
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi
$507,599Li Li · Case Western Reserve University · U01 · FY2017 · CA
Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer
$507,597Or P. Gozani · Stanford University · R01 · FY2019 · CA
Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice
$507,552Kalpana Ghoshal · Ohio State University · R01 · FY2019 · CA
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells
$507,540Xuewu Liu · Methodist Hospital Research Institute · U01 · FY2024 · CA
Early Stage Lung Cancer
$507,521Kemp Kernstine · Beckman Research Institute/City Of Hope · P01 · FY2011 · CA
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study
$507,509Cornelia M Ulrich · University Of Utah · R01 · FY2018 · CA
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$507,430Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Tissue-specific genetic interactions in cancer
$507,221Kevin Michael Haigis · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Mechanism of Eukaryotic Environmental Mutagenesis
$507,216Graham C Walker · Massachusetts Institute Of Technology · R35 · FY2021 · ES
MERTK/AXL dual inhibitors provide novel treatment for cancer by targeting tumor cells and activating anti-tumor immunity
$507,204Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
The development of novel radiation-sensitizer based on ultra-small carbon dots
$507,058Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Computational Tools for Next Generation Volumetric Cone Beam Computed Tomography
$507,036Lei Xing · Stanford University · R01 · FY2015 · EB
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis
$507,004Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2024 · CA
Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC)on Immunotherapy
$506,985Despina Kontos · Columbia University Health Sciences · R01 · FY2025 · CA
Community Outreach and Engagement
$506,901Carmen E Guerra · University Of Pennsylvania · P30 · FY2024 · CA
Developing a pharmacologic approach to treat LKB1 mutant NSCLC patients
$506,871Adam I Marcus · Emory University · R01 · FY2018 · CA
Developing a pharmacologic approach to treat LKB1 mutant NSCLC patients
$506,871Adam I Marcus · Emory University · R01 · FY2020 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$506,843Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · CA
Elucidating the role of thrombosis and inflammation in breast cancer metastasis
$506,815Takeo Fujii · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA